{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:59:15Z","timestamp":1790909955698,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk AS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014851","name":"Fundaci\u00f3n DISA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ekir.2023.07.025","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:18:39Z","timestamp":1691108319000},"page":"2029-2042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings\u00a0of the European Hyperoxaluria Consortium"],"prefix":"10.1016","volume":"8","author":[{"given":"Elisabeth L.","family":"Metry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander F.","family":"Garrelfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Deesker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Acquaviva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo B.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Collard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro Manuel","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper F.M.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Harambat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally-Anne","family":"Hulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham W.","family":"Lipkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Mandrile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Martin-Higueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufar","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbir H.","family":"Moochhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Prikhodina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Salido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezan","family":"Topaloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel J.S.","family":"Oosterveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap W.","family":"Groothoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessel","family":"Peters-Sengers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2023.07.025_bib1","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","article-title":"Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria","volume":"26","author":"Hopp","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.07.025_bib2","first-page":"119","article-title":"The clinical pattern of primary hyperoxaluria in pediatric patient at Queen Rania Abdulla Children Hospital","volume":"7","author":"Almardini","year":"2014","journal-title":"Arab J Nephrol Transplant"},{"key":"10.1016\/j.ekir.2023.07.025_bib3","first-page":"410","article-title":"Monogenic urinary lithiasis in Tunisian children: 25 years\u2019 experience of a referral center","volume":"100","author":"Boussetta","year":"2022","journal-title":"Tunis Med"},{"key":"10.1016\/j.ekir.2023.07.025_bib4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The human gene mutation database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum Genet"},{"issue":"10","key":"10.1016\/j.ekir.2023.07.025_bib5","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bbadis.2013.04.010","article-title":"Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1","volume":"1832","author":"Fargue","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ekir.2023.07.025_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ki.2014.222","article-title":"Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type","volume":"86","author":"Mandrile","year":"2014","journal-title":"Kidney Int"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2023.07.025_bib7","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/ckj\/sfab217","article-title":"Primary hyperoxaluria type 1: pathophysiology and genetics","volume":"15","author":"Fargue","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2023.07.025_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ki.2014.298","article-title":"Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria","volume":"87","author":"Tang","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.07.025_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ndt\/18.2.273","article-title":"Primary hyperoxaluria type 1 in the Netherlands: prevalence and outcome","volume":"18","author":"van Woerden","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2023.07.025_bib10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2215\/CJN.13821119","article-title":"End points for clinical trials in primary hyperoxaluria","volume":"15","author":"Milliner","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.07.025_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00467-022-05613-2","article-title":"Genetic assessment in primary hyperoxaluria: why it matters","volume":"38","author":"Mandrile","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2023.07.025_bib12","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ki.2009.32","article-title":"The primary hyperoxalurias","volume":"75","author":"Hoppe","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.07.025_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00240-016-0860-2","article-title":"Urine oxalate biological variation in patients with primary hyperoxaluria","volume":"44","author":"Clifford-Mobley","year":"2016","journal-title":"Urolithiasis"},{"key":"10.1016\/j.ekir.2023.07.025_bib14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1523-1755.2004.00796.x","article-title":"Clinical implications of mutation analysis in primary hyperoxaluria type 1","volume":"66","author":"van Woerden","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.07.025_bib15","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1073\/pnas.1131968100","article-title":"Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase","volume":"100","author":"Santana","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2023.07.025_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7812\/TPP\/19.136","article-title":"Importance of assessing compliance with conservative treatment of primary hyperoxaluria type 1: a case report of a patient with I244T\/c.969-3C>G Mutation","volume":"24","author":"Medina","year":"2020","journal-title":"Perm J"},{"key":"10.1016\/j.ekir.2023.07.025_bib17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/sj.ki.5001758","article-title":"Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: single-center experience","volume":"70","author":"Lorenzo","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.07.025_bib18","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1093\/hmg\/ddv276","article-title":"Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I","volume":"24","author":"Oppici","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.ekir.2023.07.025_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.bbapap.2010.12.005","article-title":"Human liver peroxisomal alanine:glyoxylate aminotransferase: characterization of the two allelic forms and their pathogenic variants","volume":"1814","author":"Cellini","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ekir.2023.07.025_bib20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ekir.2020.04.004","article-title":"Pyridoxine responsiveness in a Type 1 primary hyperoxaluria patient with a rare (atypical) AGXT gene mutation","volume":"5","author":"Singh","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2023.07.025_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2020.07.012","article-title":"The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: clinical features and biochemical characterization","volume":"131","author":"Dindo","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"1854","key":"10.1016\/j.ekir.2023.07.025_bib22","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.bbapap.2015.07.002","article-title":"Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine","volume":"10","author":"Montioli","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ekir.2023.07.025_bib23","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.bbadis.2013.09.002","article-title":"Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase","volume":"1832","author":"Oppici","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ekir.2023.07.025_bib24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2215\/CJN.06820613","article-title":"Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice","volume":"9","author":"Hoyer-Kuhn","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.07.025_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2215\/CJN.02810315","article-title":"Predictors of incident ESRD among patients with primary hyperoxaluria presenting prior to kidney failure","volume":"11","author":"Zhao","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.07.025_bib26","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/000456329102800615","article-title":"Biological variation of\u00a0urinary oxalate in different specimen types","volume":"28","author":"Balchin","year":"1991","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ekir.2023.07.025_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41581-022-00661-1","article-title":"Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope","volume":"19","author":"Groothoff","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2023.07.025_bib28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000280294","article-title":"Renal elimination kinetics and plasma half-life of oxalate in man","volume":"34","author":"Osswald","year":"1979","journal-title":"Urol Int"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923014043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923014043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:26:55Z","timestamp":1763368015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024923014043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2468024923014043"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2023.07.025","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings\u00a0of the European Hyperoxaluria Consortium","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2023.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}